Variant report
| Variant | esv3520105 |
|---|---|
| Chromosome Location | chr10:50204729-50207237 |
| allele | n/a |
| Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
| No data |
| No data |
| No data |
| No data |
| No data |
| No data |
| No data |
| No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
|---|---|---|---|---|---|---|---|
| 1 | rs193031524 | chr10:50204752-50204753 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
| 2 | rs569880613 | chr10:50204850-50204851 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
| 3 | rs35766298 | chr10:50204860-50204861 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
| 4 | rs536971946 | chr10:50204890-50204891 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
| 5 | rs2264843 | chr10:50204956-50204957 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
| 6 | rs566933430 | chr10:50204972-50204973 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
| 7 | rs534274237 | chr10:50204977-50204978 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
| 8 | rs7914464 | chr10:50204985-50204986 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
| 9 | rs151093581 | chr10:50204986-50204987 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
| 10 | rs113688536 | chr10:50204995-50204996 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
| 11 | rs77667722 | chr10:50205000-50205001 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
| 12 | rs576529818 | chr10:50205034-50205035 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
| 13 | rs375039393 | chr10:50205080-50205081 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
| 14 | rs114182323 | chr10:50205081-50205082 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
| 15 | rs115148717 | chr10:50205082-50205083 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
| 16 | rs539236392 | chr10:50205097-50205098 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
| 17 | rs541430491 | chr10:50205099-50205100 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
| 18 | rs559627351 | chr10:50205101-50205102 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
| 19 | rs34199942 | chr10:50205242-50205243 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
| 20 | rs546141503 | chr10:50205281-50205282 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
| 21 | rs28818556 | chr10:50205302-50205303 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
| 22 | rs551557174 | chr10:50205328-50205329 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
| 23 | rs185719094 | chr10:50205353-50205354 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
| 24 | rs530578620 | chr10:50205364-50205365 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
| 25 | rs548868354 | chr10:50205380-50205381 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
| 26 | rs189804281 | chr10:50205388-50205389 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
| 27 | rs181748758 | chr10:50205390-50205391 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
| 28 | rs184107516 | chr10:50205397-50205398 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
| 29 | rs546559325 | chr10:50205417-50205418 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
| 30 | rs201560719 | chr10:50205436-50205437 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
| 31 | rs188787648 | chr10:50205458-50205459 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
| 32 | rs548770043 | chr10:50205465-50205466 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
| 33 | rs562171389 | chr10:50205479-50205480 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
| 34 | rs571281536 | chr10:50205488-50205489 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
| 35 | rs368335367 | chr10:50205497-50205498 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
| 36 | rs538746702 | chr10:50205550-50205551 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
| 37 | rs556745122 | chr10:50205552-50205553 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
| 38 | rs576585466 | chr10:50205596-50205597 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
| 39 | rs181350216 | chr10:50205609-50205610 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
| 40 | rs556139054 | chr10:50205640-50205641 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
| 41 | rs376636265 | chr10:50205661-50205662 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
| 42 | rs7895063 | chr10:50205666-50205667 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
| 43 | rs145510547 | chr10:50205667-50205668 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
| 44 | rs559720642 | chr10:50205678-50205679 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
| 45 | rs36006809 | chr10:50205755-50205756 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
| 46 | rs577925524 | chr10:50205763-50205764 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
| 47 | rs140256429 | chr10:50205774-50205775 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
| 48 | rs563586250 | chr10:50205792-50205793 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
| 49 | rs530664675 | chr10:50205800-50205801 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
| 50 | rs372997444 | chr10:50205867-50205868 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
| Disease | PMID | Source |
|---|---|---|
| Pancreatic endocrine tumor | 17639061 | CNVD |
| Gastric cancer | 17908304 | CNVD |
| Chordoma | 21602918 | CNVD |
| Ewing''s sarcoma | 21437220 | CNVD |
| Glioblastoma multiforme | 21080181 | CNVD |
| Medulloblastoma | 21979893 | CNVD |
| Melanoma | 18172304 | CNVD |
| Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
| Thoracic aortic aneurysm | 21092924 | CNVD |
| Ewing''s sarcoma | 17952124 | CNVD |
| T-cell prolymphocytic leukemia | 19278963 | CNVD |
| Hodgkin''s lymphoma | 17606441 | CNVD |
| Acute lymphoblastic leukemia | 20435627 | CNVD |
| Acute lymphoblastic leukemia | 20724749 | CNVD |
| Autism | 22495311 | CNVD |
| Esophageal cancer | 21851588 | CNVD |
| Prostate cancer | 18632612 | CNVD |
| Autism | 18414403 | CNVD |
| Cockayne syndrome | 18421352 | CNVD |
| Glioblastoma | 16823260 | CNVD |
| Medulloblastoma | 16968546 | CNVD |
| Neuroblastoma | 17533364 | CNVD |
| Cancer | 21183584 | CNVD |
| T-cell lymphomas | 19863542 | CNVD |
| Testicular germ cell tumor | 18059402 | CNVD |
| Squamous cell cancer | 21044232 | CNVD |
| Glioma | 21971842 | CNVD |
| Cancer | 21637783 | CNVD |
| Non-small cell lung cancer | 21044232 | CNVD |
| Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
| Colorectal cancer | 20709793 | CNVD |
| Endometrial cancer | 22040021 | CNVD |
| Breast cancer | 21264507 | CNVD |
| Esophageal squamous carcinoma | 21637470 | CNVD |
| Liposarcoma | 21253554 | CNVD |
| Oligodendroglial tumors | 17285580 | CNVD |
| Chronic lymphocytic leukemia | 21546498 | CNVD |
| Papillary thyroid carcinoma | 21436994 | CNVD |
| Hirschsprung''s Disease | 21712996 | CNVD |
| Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
| Obesity | 21956041 | CNVD |
| Renal cell carcinoma | 18765545 | CNVD |
| Developmental delay | 21948486 | CNVD |
| Dysmorphic features | 21948486 | CNVD |
| Epilepsy | 21948486 | CNVD |
| Breast cancer | 21785460 | CNVD |
| Intellectual disability | 21948486 | CNVD |
| Schizophrenia | 23813976 | CNVD |
| Intellectual disability | 22045946 | CNVD |
| Basal cell lymphoma | 16317097 | CNVD |
| Diffuse large b-cell lymphoma | 16317097 | CNVD |
| Autism | 21948486 | CNVD |
| cleft palate | 21948486 | CNVD |
| Encephalopathy | 21948486 | CNVD |
| Lung cancer | 18438408 | CNVD |
| T-cell primary immunodeficiency | 21948486 | CNVD |
| Autism | 22543975 | CNVD |
| Breast cancer | 21364760 | CNVD |
| Developmental delay | 21147756 | CNVD |
| small cell lung cancer | 20016488 | CNVD |
| skeletal anomalies | 21948486 | CNVD |
| speech delay | 21948486 | CNVD |
| Colorectal cancer | 16272173 | CNVD |
| Breast cancer | 21990379 | CNVD |
| Myelofibrosis | 22110671 | CNVD |
| Metanephric adenoma | 20802469 | CNVD |
| Cancer | 20164919 | CNVD |
| Breast cancer | 22522925 | CNVD |
| No. | Chromosome Location | Chromatin state | Cell line | Tissue |
|---|---|---|---|---|
| 1 | chr10:50204400-50205000 | Enhancers | Fetal Intestine Large | intestine |
| 2 | chr10:50204400-50205200 | Enhancers | Fetal Intestine Small | intestine |
| 3 | chr10:50205000-50206600 | Weak transcription | Fetal Intestine Large | intestine |
| 4 | chr10:50205200-50206200 | Weak transcription | Fetal Intestine Small | intestine |
| 5 | chr10:50206200-50210400 | Enhancers | Duodenum Mucosa | Duodenum |
| 6 | chr10:50206200-50211200 | Enhancers | Fetal Intestine Small | intestine |
| 7 | chr10:50206600-50211000 | Enhancers | Fetal Intestine Large | intestine |
| 8 | chr10:50206800-50209800 | Enhancers | Stomach Mucosa | stomach |






